Renalytix plc
RENXF- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001811115
No open-market purchases or sales by Renalytix plc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesRNLXY
Holders of 5% or more of RENXF
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Renalytix plc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Renalytix plc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on Renalytix plc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 23, 20264:21 PM ET | Jefferson River Capital LLCand 3 others | 13D/A | 4.50%19.6M shares | –Below 5% | Nov 4, 2025 | SEC |
| Apr 30, 20254:41 PM ET | UBS Group AG | 13G/A | 0.00%0 shares | 0.00 ppfrom 0.00%Below 5% | Mar 31, 2025 | SEC |
| Apr 30, 20254:15 PM ET | UBS Group AG | 13G/A | 0.00%0 shares | −5.10 ppfrom 5.10%Below 5% | Dec 31, 2024 | SEC |
| Feb 10, 20259:26 AM ET | UBS Group AG | 13G | 5.10%16.8M shares | New | Dec 31, 2024 | SEC |
| Nov 14, 2024 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | Jefferson River Capital LLC | 13D/AOld format | – | – | – | SEC |
| Nov 5, 2024 | Icahn School of Medicine at Mount Sinai | 13D/AOld format | – | – | – | SEC |
| Oct 2, 2024 | Jefferson River Capital LLC | 13D/AOld format | – | – | – | SEC |
| Apr 26, 2024 | Icahn School of Medicine at Mount Sinai | 13D/AOld format | – | – | – | SEC |
| Apr 4, 2024 | CVI Investments, Inc. | 13GOld format | – | New | – | SEC |
| Mar 21, 2024 | Jefferson River Capital LLC | 13D/AOld format | – | – | – | SEC |
| Feb 17, 2023 | Jefferson River Capital LLC | 13DOld format | – | New | – | SEC |
| Feb 14, 2023 | Gilder Gagnon Howe & Co LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Icahn School of Medicine at Mount Sinai | 13DOld format | – | – | – | SEC |
| May 27, 2022 | Icahn School of Medicine at Mount Sinai | 13G/AOld format | – | – | – | SEC |
| May 27, 2022 | Icahn School of Medicine at Mount Sinai | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Gilder Gagnon Howe & Co LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Gilder Gagnon Howe & Co LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Renalytix plc shares.
No Form 144 notices for Renalytix plc are on file.